NEUMODX MOLECULAR
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing in hospital and clinical reference laboratories.
NEUMODX MOLECULAR
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2012-01-01
Address:
Ann Arbor, Michigan, United States
Country:
United States
Website Url:
http://www.neumodx.com
Total Employee:
51+
Status:
Active
Contact:
(734)477-0111
Total Funding:
66.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Current Advisors List
Board_member
Current Employees Featured
Jeff Williams Chairman & CEO @ NeuMoDx Molecular
Chairman & CEO
2011-04-01
Founder
Investors List
Arboretum Ventures
Arboretum Ventures investment in Series B - NeuMoDx Molecular
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - NeuMoDx Molecular
Wolverine Venture Fund
Wolverine Venture Fund investment in Series B - NeuMoDx Molecular
Venture Investors
Venture Investors investment in Series B - NeuMoDx Molecular
Baird Capital
Baird Capital investment in Series B - NeuMoDx Molecular
Wolverine Venture Fund
Wolverine Venture Fund investment in Series A - NeuMoDx Molecular
Official Site Inspections
http://www.neumodx.com
- Host name: ec2-18-220-162-78.us-east-2.compute.amazonaws.com
- IP address: 18.220.162.78
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "NeuMoDx Molecular"
NeuMoDx Molecular System - QIAGEN
NeuMoDx Molecular Systems combine automated nucleic acid extraction, amplification and detection on a single instrument. The NeuMoDx instruments are the industry’s first true random-access system that are scalable according to …See details»
QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out …
Sep 17, 2020 · • Transaction strengthens QIAGEN’s leadership position in automated molecular testing • QIAGEN acquires remaining 80.1% stake in NeuMoDx Molecular, Inc. for $248 …See details»
NeuMoDx Molecular - Crunchbase Company Profile
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing in hospital and clinical reference laboratories.See details»
QIAGEN to discontinue NeuMoDx integrated PCR testing system, …
Jun 6, 2024 · QIAGEN has started discussions with NeuMoDx customers to review implications of this decision on the 2024 NeuMoDx sales forecast for at least $55 million CER. QIAGEN plans …See details»
NeuMoDx Molecular Systems | Automated PCR - QIAGEN
NeuMoDx 288 and NeuMoDx 96 Molecular Systems are fully automated, continuous random-access analyzers. These instruments use proprietary NeuDry reagent technology, which …See details»
QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out …
Sep 17, 2020 · QIAGEN acquires remaining 80.1% stake in NeuMoDx Molecular, Inc. for $248 million Medium- and high-throughput NeuMoDx automation solutions based on PCR testing …See details»
NeuMoDx transplant-associated virus assays - QIAGEN
NeuMoDx simplifies infectious disease diagnostics so you can get faster results for your patients. NeuMoDx Molecular Systems provide a fully integrated molecular diagnostic process from …See details»
Qiagen acquires NeuMoDx Molecular - 2020-09-17 - Crunchbase
Dec 24, 2020 · NeuMoDx — QIAGEN and NeuMoDx™ announce strategic partnership to offer next generation systems for fully integrated molecular diagnostic testingSee details»
Qiagen completes takeover of PCR automation player NeuMoDx …
Sep 18, 2020 · Qiagen has exercised its option to acquire NeuMoDx Molecular for its portfolio of PCR-based diagnostic automation systems. The deal, which has already received regulatory …See details»
Qiagen Partners with NeuMoDx on PCR-Based MDx …
Sep 17, 2018 · Qiagen will commercialize two new fully-integrated systems for automation of PCR (polymerase chain reaction) testing developed by NeuMoDx Molecular in major markets outside the U.S., the companies said today, …See details»
Labs like yours rely on NeuMoDx - Qiagen
NeuMoDx delivers a new solution for the collection of saliva samples that, compared with nasopharyngeal testing, is non-invasive, decreases patient discomfort and is associated with reduced costs.* Connect with a specialist to …See details»
NeuMoDx respiratory assays US - QIAGEN
The NeuMoDx SARS-CoV-2 Assay is a real-time RT-PCR diagnostic test for the qualitative detection of SARS-CoV-2 coronavirus RNA in nasal, nasopharyngeal and oropharyngeal …See details»
QIAGEN to discontinue NeuMoDx integrated PCR testing system, …
Jun 6, 2024 · QIAGEN understands the impact of this decision on its customers and will continue to provide support for existing NeuMoDx users during a transition period into 2025. This …See details»
NeuMoDx | Lab Manager
QIAGEN and NeuMoDx Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing by QIAGEN and NeuMoDx QIAGEN to launch two Sample to Insight systems in …See details»
Multicenter evaluation of the NeuMoDxâ„¢ SARS-CoV-2 Test
Aug 7, 2020 · The NeuMoDx SARS-CoV-2 assay (NeuMoDx™ Molecular, Ann Arbor, Michigan) is a fully automated, rapid real-time RT-PCR that detects two conserved regions of the non …See details»
Performances of NeuMoDx™, a random-access system for …
Monitoring of viral loads (VL) for hepatitis B and C viruses (HBV; HCV) is essential to evaluate disease progression and treatment response. Automated, random-access rapid systems are …See details»
QIAGEN and NeuMoDx announce strategic partnership to offer …
Sep 17, 2018 · Hilden, Germany, and Ann Arbor, Michigan, September 17, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today …See details»
QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx …
Mar 29, 2021 · QIAGEN’s new respiratory test takes advantage of the NeuMoDx 96 and NeuMoDx 288 molecular systems’ automated three-step workflow.See details»
Multicenter evaluation of the NeuMoDxâ„¢ SARS-CoV-2 Test
The NeuMoDx™ SARS-CoV-2 assay, performed on a NeuMoDx molecular system, is a rapid, fully automated, qualitative real-time RT-PCR diagnostic test with throughput of up to 288 tests …See details»
Performances of NeuMoDx™, a random-access system for …
Nov 1, 2021 · Results obtained on the NeuMoDx™ confirmed the overall good functionality of the system with a short turn-around-time, full traceability and easy handling. These results on HBV …See details»